Form 4: Sarepta CFO's Stock Sale for Tax Obligations
Insider Transaction Report
Sarepta Therapeutics' CFO, Ryan Ho-Yan Wong, disposed of 158 shares of common stock on December 1, 2025, to cover tax withholding obligations from RSU vesting.
Summary
- Ryan Ho-Yan Wong, Chief Financial Officer of Sarepta Therapeutics, Inc. (SRPT), reported a disposition of common stock.
- The transaction occurred on December 1, 2025, and involved the withholding of shares by the company to satisfy tax obligations.
- A total of 80 shares were withheld at a price of $20.96 per share, related to restricted stock units granted on November 30, 2021.
- An additional 78 shares were withheld at a price of $20.96 per share, related to restricted stock units granted on November 30, 2022.
- Following these transactions, Ryan Ho-Yan Wong beneficially owns 136,045 shares of Sarepta Therapeutics common stock directly.
Sentiment
Score: 5
Explanation: Neutral, as the filing reports a routine, non-discretionary transaction for tax withholding purposes related to vested equity compensation. This type of transaction is common and generally does not indicate a change in management's outlook or company fundamentals.
Future Outlook
This filing does not contain any forward-looking statements or guidance.
Industry Context
This is a routine insider transaction related to equity compensation and tax obligations, which is common across all industries for executives receiving restricted stock units. It does not reflect broader industry trends or competitive positioning.
Stakeholder Impact
- Shareholders: Minimal impact, as this is a routine, non-discretionary transaction for tax purposes and does not reflect a change in the CFO's investment thesis or company performance.
Key Dates
| Date | Description |
|---|---|
| 11/30/2021 | Grant date of restricted stock units (RSUs) for which 80 shares were withheld for tax obligations. |
| 11/30/2022 | Grant date of restricted stock units (RSUs) for which 78 shares were withheld for tax obligations. |
| 12/01/2025 | Transaction date for the disposition of common stock to satisfy tax withholding obligations. |
| 12/10/2025 | Date the Form 4 was signed by the Attorney-in-Fact for Ryan Ho-Yan Wong. |
Keywords
Sarepta Therapeutics, SRPT, Ryan Ho-Yan Wong, CFO, Insider Transaction, Form 4, Stock Sale, Tax Withholding, Restricted Stock Units, Equity Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.